Glaukos Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GKOS research report →
Companywww.glaukos.com
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication.
- CEO
- Thomas William Burns
- IPO
- 2015
- Employees
- 995
- HQ
- Aliso Viejo, CA, US
Price Chart
Valuation
- Market Cap
- $8.45B
- P/E
- -44.08
- P/S
- 15.32
- P/B
- 12.44
- EV/EBITDA
- -211.21
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 78.08%
- Op Margin
- -15.58%
- Net Margin
- -34.34%
- ROE
- -26.46%
- ROIC
- -10.40%
Growth & Income
- Revenue
- $507.44M · 32.33%
- Net Income
- $-187,691,000 · -28.23%
- EPS
- $-3.28 · -18.41%
- Op Income
- $-86,733,000
- FCF YoY
- 20.13%
Performance & Tape
- 52W High
- $148.11
- 52W Low
- $73.16
- 50D MA
- $119.52
- 200D MA
- $104.59
- Beta
- 0.95
- Avg Volume
- 732.45K
Get TickerSpark's AI analysis on GKOS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 14, 26 | Kliman Gilbert H | other | 5,000 |
| May 14, 26 | Kliman Gilbert H | sell | 5,000 |
| May 14, 26 | Kliman Gilbert H | other | 5,000 |
| May 11, 26 | Kliman Gilbert H | other | 5,000 |
| May 11, 26 | Kliman Gilbert H | sell | 5,000 |
| May 11, 26 | Kliman Gilbert H | other | 5,000 |
| Apr 30, 26 | Thurman Alex R. | other | 10,000 |
| Apr 30, 26 | Thurman Alex R. | sell | 10,000 |
| Apr 30, 26 | Thurman Alex R. | other | 10,000 |
| May 1, 26 | Gilliam Joseph E | sell | 19,573 |
Our GKOS Coverage
We haven't published any research on GKOS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GKOS Report →